| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1041880A4 A delivery of arginine to cause beneficial effects |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0972042B1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0912179B1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/12/2006 | CN1758924A Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 04/12/2006 | CN1758913A Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 04/12/2006 | CN1758903A Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same |
| 04/12/2006 | CN1757646A Inhibitors of nucleoside metabolism |
| 04/12/2006 | CN1757413A Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 04/12/2006 | CN1757391A Application of neutral berberine sulfate for preparing medicine to treat and prepvent endotoxic diseases |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250548C Novel adenine derivatives |
| 04/12/2006 | CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives |
| 04/12/2006 | CN1250531C Novel compounds |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250295C Magnetism and drug combined type fragrant baldric for avoiding plague |
| 04/12/2006 | CN1250290C Novel medicament compositions, based on anticholinergic effective compounds and beta-mimetiques |
| 04/12/2006 | CN1250289C Drugs, drinks or foods |
| 04/12/2006 | CN1250283C Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 04/12/2006 | CN1250281C Method for treating endothelium wound |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250278C Oral medicine for treating dementia and feeblemindedness |
| 04/12/2006 | CN1250267C Health-care product for improving sleep and increasing bone density and preparation method |
| 04/12/2006 | CN1250257C Granule for clearing away the lung-heat and removing poison |
| 04/12/2006 | CN1250246C Medicinal mixture possessing alpha glycocidase inhibiting activity and its use |
| 04/12/2006 | CN1250234C Magnetism and drug combined type health care pillow for mind easing and avoiding plague and preparation method |
| 04/12/2006 | CN1250226C Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tboc amino-phenyl)ethoxy]phenyl}-(S)-2-ethoxy propionic ac |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250219C Pharmaceutical composition |
| 04/12/2006 | CN1250218C Use of angiotensin II antagonists |
| 04/12/2006 | CN1250209C Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme |
| 04/12/2006 | CN1250115C Use of lignan in foods |
| 04/12/2006 | CN1250097C Health-care and nutrient oil with functions of fatigue-resistance and lowering blood fat |
| 04/11/2006 | US7026516 Compounds with high monoamine transporter affinity |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026488 A hemeoxygenase inhibitory metalloprotoporphyrin derivative, especially Zn-protoporphyrin, conjugated with an amphipathic or water soluble polymer; anticarcinogenic agents with little side effect and excellent tumor accumulation; very potent and efficient; administered by intravenous injection; stability |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026356 Fatty acid analogues for the treatment of diseases caused by the pathological proliferation of smooth muscle cells |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026334 Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| 04/11/2006 | US7026332 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, and other psychological disorders |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 04/11/2006 | US7026327 2-etherified 4-fluoroalkyl-6-(p-sulfonylphenyl)pyrimidines,e.g., 2-(4-fluorophenoxy)-4-[4-(methylsulfonyl)phenyl]-6](trifluoromethyl)pyrimidine; treatment of the pain, fever and inflammation of variety of conditions and diseases |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026323 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/11/2006 | US7026304 especially for blocking rocuronium, vecuronium, pancuronium and rapacuronium salts; kits. |
| 04/11/2006 | US7026297 Neuroprotective agents |
| 04/11/2006 | US7026293 Comprising active ingredient such as atrial natriuretic peptide which can increase cGMP production by acting on natriuretic peptide receptor, and which reduces an infarct region |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026140 Serum paraoxonase |
| 04/11/2006 | US7026136 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025960 For therapy of diseases which can be treated or alleviated by a stimulation of the production of cytokines, particularly of IL-12 |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/11/2006 | CA2282840C S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006035897A1 Composition inhibiting sex hormone-binding globulin |
| 04/06/2006 | WO2006035796A1 1-(β-D-GLYCOPYRANOSYL)-3-SUBSTITUTED NITROGENOUS HETEROCYCLIC COMPOUND, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE THEREOF |
| 04/06/2006 | WO2006035702A1 C-peptide specific binding molecule and use thereof |
| 04/06/2006 | WO2006035700A1 Composition containing proanthocyanidin and sphingolipid |
| 04/06/2006 | WO2006035673A1 Novel method of protecting ischemic cardiopathy |
| 04/06/2006 | WO2006035622A1 In vivo nerve nutrition factor producing method using alternating high potential and in vivo nerve nutrition factor producing device |
| 04/06/2006 | WO2006035617A1 α2 RECEPTOR BLOCKING AGENT CONTAINING INDOLE DERIVATIVE AS ACTIVE INGREDIENT AND VASODILATOR |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074111 Chemical compounds |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074095 Novel purine derivatives, preparation method and use as medicines |
| 04/06/2006 | US20060074094 Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074091 Nootropic effect enhancer |
| 04/06/2006 | US20060074090 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety |